| Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Sep 24 | Sep 23 | Sep 22 | Sep 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 93.31 mm | 93.31 mm | 93.31 mm | 93.31 mm | 93.31 mm | 93.31 mm |
| Cash burn (monthly) | 3.47 mm | (no burn) | 3.23 mm | 2.69 mm | 2.16 mm | 1.87 mm |
| Cash used (since last report) | 7.15 mm | n/a | 6.66 mm | 5.55 mm | 4.45 mm | 3.85 mm |
| Cash remaining | 86.16 mm | n/a | 86.65 mm | 87.77 mm | 88.86 mm | 89.46 mm |
| Runway (months of cash) | 24.9 | n/a | 26.8 | 32.6 | 41.2 | 47.9 |
| 13F holders | Current |
|---|---|
| Total holders | 52 |
| Opened positions | 23 |
| Closed positions | 11 |
| Increased positions | 8 |
| Reduced positions | 6 |
| 13F shares | Current |
|---|---|
| Total value | 58.85 bn |
| Total shares | 51.64 mm |
| Total puts | 15.10 k |
| Total calls | 24.10 k |
| Total put/call ratio | 0.6 |
| Largest owners | Shares | Value |
|---|---|---|
| Biotechnology Value Fund L P | 8.75 mm | $23.53 mm |
| BVF | 8.75 mm | $15.66 bn |
| Tang Capital Management | 4.30 mm | $7.70 bn |
| BML Investment Partners | 4.22 mm | $7.30 mm |
| BML Capital Management | 4.22 mm | $7.56 bn |
| MS Morgan Stanley | 4.20 mm | $7.51 bn |
| Soleus Capital | 2.26 mm | $3.91 mm |
| Soleus Capital Management | 2.26 mm | $4.05 bn |
| Opaleye Management | 2.21 mm | $3.96 bn |
| Clarus Lifesciences III | 2.19 mm | $26.71 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Nov 24 | Growth N V Biotech | Common Shares | Sell | Dispose S | No | No | 1.513 | 1,879,583 | 2.84 mm | 0 |
| 1 Nov 24 | Growth N V Biotech | Common Shares | Sell | Dispose S | No | No | 1.5294 | 2,000,000 | 3.06 mm | 1,879,583 |
| 1 Nov 24 | Growth N V Biotech | Common Shares | Sell | Dispose S | No | No | 1.5259 | 2,000,000 | 3.05 mm | 3,879,583 |
| 1 Nov 24 | Growth N V Biotech | Common Shares | Sell | Dispose S | No | No | 1.532 | 2,000,000 | 3.06 mm | 5,879,583 |
| 7 Oct 24 | Peter Virsik | Common Shares | Sell | Dispose S | No | Yes | 6.03 | 694 | 4.18 k | 7,776 |
| 9 Sep 24 | Peter Virsik | Common Shares | Sell | Dispose S | No | Yes | 6 | 694 | 4.16 k | 8,470 |
| 3 Sep 24 | Peter Virsik | Common Shares | Sell | Dispose S | No | Yes | 6.03 | 2,082 | 12.55 k | 9,164 |
| 6 May 24 | Peter Virsik | Common Shares | Sell | Dispose S | No | Yes | 6.95 | 694 | 4.82 k | 11,246 |
